JP2013518812A5 - - Google Patents

Download PDF

Info

Publication number
JP2013518812A5
JP2013518812A5 JP2012549078A JP2012549078A JP2013518812A5 JP 2013518812 A5 JP2013518812 A5 JP 2013518812A5 JP 2012549078 A JP2012549078 A JP 2012549078A JP 2012549078 A JP2012549078 A JP 2012549078A JP 2013518812 A5 JP2013518812 A5 JP 2013518812A5
Authority
JP
Japan
Prior art keywords
alkyl
alkenyl
aryl
halo
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012549078A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013518812A (ja
JP5887672B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/021129 external-priority patent/WO2011088209A2/en
Publication of JP2013518812A publication Critical patent/JP2013518812A/ja
Publication of JP2013518812A5 publication Critical patent/JP2013518812A5/ja
Application granted granted Critical
Publication of JP5887672B2 publication Critical patent/JP5887672B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012549078A 2010-01-13 2011-01-13 ビタミンｄ関連化合物の１−デオキシ類似体 Expired - Fee Related JP5887672B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US29474110P 2010-01-13 2010-01-13
US61/294,741 2010-01-13
PCT/US2011/021129 WO2011088209A2 (en) 2010-01-13 2011-01-13 1-deoxy analogs of vitamin d-related compounds

Related Child Applications (3)

Application Number Title Priority Date Filing Date
JP2015136521A Division JP2016006056A (ja) 2010-01-13 2015-07-07 ビタミンｄ関連化合物の１−デオキシ類似体
JP2015136522A Division JP2015212294A (ja) 2010-01-13 2015-07-07 ビタミンｄ関連化合物の１−デオキシ類似体
JP2015136520A Division JP2016006055A (ja) 2010-01-13 2015-07-07 ビタミンｄ関連化合物の１−デオキシ類似体

Publications (3)

Publication Number Publication Date
JP2013518812A JP2013518812A (ja) 2013-05-23
JP2013518812A5 true JP2013518812A5 (https=) 2014-03-06
JP5887672B2 JP5887672B2 (ja) 2016-03-16

Family

ID=44010128

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2012549078A Expired - Fee Related JP5887672B2 (ja) 2010-01-13 2011-01-13 ビタミンｄ関連化合物の１−デオキシ類似体
JP2015136521A Pending JP2016006056A (ja) 2010-01-13 2015-07-07 ビタミンｄ関連化合物の１−デオキシ類似体
JP2015136522A Pending JP2015212294A (ja) 2010-01-13 2015-07-07 ビタミンｄ関連化合物の１−デオキシ類似体
JP2015136520A Pending JP2016006055A (ja) 2010-01-13 2015-07-07 ビタミンｄ関連化合物の１−デオキシ類似体

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2015136521A Pending JP2016006056A (ja) 2010-01-13 2015-07-07 ビタミンｄ関連化合物の１−デオキシ類似体
JP2015136522A Pending JP2015212294A (ja) 2010-01-13 2015-07-07 ビタミンｄ関連化合物の１−デオキシ類似体
JP2015136520A Pending JP2016006055A (ja) 2010-01-13 2015-07-07 ビタミンｄ関連化合物の１−デオキシ類似体

Country Status (3)

Country Link
US (3) US9775903B2 (https=)
JP (4) JP5887672B2 (https=)
WO (1) WO2011088209A2 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9775903B2 (en) * 2010-01-13 2017-10-03 Johns Hopkins University 1-deoxy analogs of 1,25-dihydroxyvitamin D3 compounds
GB2512314A (en) * 2013-03-26 2014-10-01 Kartar Singh Lalvani Statin composition
CN105348163B (zh) * 2014-08-18 2017-06-16 武汉启瑞药业有限公司 维生素d类似物及其制备方法和医药用途
EP3639854B1 (en) 2017-06-16 2026-01-07 The Doshisha Mtor-inhibitor-containing medicine for treating or preventing fuchs' endothelial corneal dystrophy
EP4232012A4 (en) * 2020-10-23 2024-12-11 Massachusetts Institute of Technology Methods and compositions for differentiating stem cells
WO2025094144A1 (en) 2023-11-02 2025-05-08 Eirgen Pharma Ltd. Controlling loss of kidney function

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5830885A (en) 1992-03-12 1998-11-03 The Johns Hopkins University Antiproliferative vitamin D3 hybrids
ATE344039T1 (de) * 1999-04-01 2006-11-15 Univ Johns Hopkins Nicht-calcemische, transkriptionell-aktive, schwefelhaltige analoga von 1-alpha, 25- dihydroxyvitamin d3 mit antiproliferativer wirkung
AU7947200A (en) * 1999-10-19 2001-04-30 Juichiro Nakayama Remedies for pigmentation and melanocyte proliferation inhibitors
JP2002104995A (ja) * 2000-09-29 2002-04-10 Masahiko Hosaka テロメラーゼ活性抑制剤
US7166585B2 (en) * 2001-08-22 2007-01-23 Cytochroma Inc. 24-Sulfur-substituted analogs of 1α,25-dihydroxy vitamin D3
JP4436674B2 (ja) * 2001-10-12 2010-03-24 ジョンズ ホプキンス ユニバーシティ １α，２５−ジヒドロキシビタミンＤ３の低カルシウム血症性オキシム類似体
ATE543796T1 (de) * 2002-06-13 2012-02-15 Univ Johns Hopkins 24-sulfoximine vitamin d3 derivate
WO2004002996A1 (ja) * 2002-06-27 2004-01-08 Chugai Seiyaku Kabushiki Kaisya フェロセン化合物およびその用途
BR0315553A (pt) * 2002-10-23 2005-08-23 Leo Pharma As Composto, composição farmacêutica, método de tratamento ou profilaxia de doenças, método de tratamento ou profilaxia de hiperparatireoidismo secundário, e, uso de um composto, opcionalmente em conjunto com outro composto terapeuticamente ativo
CA2510228C (en) 2002-12-18 2012-10-30 Johns Hopkins University 25-so2-substituted analogs of 1.alpha.,25-dihydroxyvitamin d3
WO2006113990A2 (en) * 2005-04-25 2006-11-02 Cytochroma Inc. LOW-CALCEMIC 16,23-DIENE 25-OXIME ANALOGS OF 1α ,25-DIHYDROXY VITAMIN D3
JP4882050B2 (ja) * 2006-03-15 2012-02-22 日本マイクロバイオファーマ株式会社 インデン誘導体の製造方法およびその製造中間体
WO2008035207A2 (en) 2006-04-06 2008-03-27 Wisconsin Alumni Research Foundation 2-methylene-1alpha-hydroxy-19,21-dinorvitamin d3 analogs and uses thereof
US9775903B2 (en) * 2010-01-13 2017-10-03 Johns Hopkins University 1-deoxy analogs of 1,25-dihydroxyvitamin D3 compounds

Similar Documents

Publication Publication Date Title
JP2013518812A5 (https=)
JP5113766B2 (ja) ビタミンｄ類似体：ｒａｋ、その方法および使用
JP2005536444A5 (https=)
US7259143B2 (en) Method of extending the dose range of vitamin D compounds
RU2013128973A (ru) Соединения, активные в отношении кальций-чувствительных рецепторов
JP2009525980A (ja) ビタミンｄ類似体：ｎｅｌ、その方法および使用
US20080249068A1 (en) Method of Extending the Dose Range of Vitamin D Compounds
US20190060456A1 (en) 1-deoxy analogs of vitamin d-related compounds
JP2019510045A5 (https=)
Wietrzyk et al. Toxicity and antineoplastic effect of (24R)-1, 24-dihydroxyvitamin D3 (PRI-2191)
CA3034453A1 (en) Compositions comprising pikfyve inhibitors and methods related to inhibition of rank signaling
Wietrzyk et al. The antitumor effect of lowered doses of cytostatics combined with new analogs of vitamin D in mice
Wietrzyk et al. Toxicity and antitumor activity of the vitamin D analogs PRI-1906 and PRI-1907 in combined treatment with cyclophosphamide in a mouse mammary cancer model
Choi et al. Therapeutic targets of vitamin D receptor ligands and their pharmacokinetic effects by modulation of transporters and metabolic enzymes
JP2007505883A (ja) ２−アルキリデン−１９−ノル−ビタミンｄ誘導体及び副甲状腺ホルモンの組合せを含んでなる医薬組成物及び方法
Brown et al. The vitamin D analog 1α, 25-dihydroxy-2β-(3-hydroxypropyloxy) vitamin D3 (eldecalcitol) is a potent regulator of calcium and phosphate metabolism
JP2013522369A (ja) （２０Ｓ）−２−メチレン−１９−ノル−２２−ジメチル−１α，２５−ジヒドロキシビタミンＤ３および（２０Ｒ）−２−メチレン−１９−ノル−２２−ジメチル−１α，２５−ヒドロキシビタミンＤ３
Chen et al. Novel vitamin d analogs for prostate cancer therapy
Brown et al. Vitamin D analogs: new therapeutic agents for secondary hyperparathyroidism
WO2006113990B1 (en) LOW-CALCEMIC 16,23-DIENE 25-OXIME ANALOGS OF 1α ,25-DIHYDROXY VITAMIN D3
JP5652723B2 (ja) マキサカルシトールの新しい結晶形態
US9663429B2 (en) Vitamin D analogues of pharmaceutical interest
CA2986694A1 (en) 1.alpha.,25-dihydroxy-24,24-difluoro-19-nor-vitamin d3 analogs and their pharmaceutical uses
Williams et al. 2-Methylene-19-nor-20 (S)-1α-hydroxy-bishomopregnacalciferol [20 (S)-2MbisP], an analog of vitamin D3 [1, 25 (OH) 2D3], does not stimulate intestinal phosphate absorption at levels previously shown to suppress parathyroid hormone
Pasquali et al. Further vitamin D analogs